8WHO. WHO position paper on Haemophilus influenzae type b conjugate vaccines, WER, 2006,81 (47) : 445-452.
9Lagos R, Kotloff K, San Martin O, et al. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two- , four-and six-month-old Chilean children. Pediatr Infect Dis J, 1998, 17:294-304.
10Data on file/E2103294/Open, randomised, comparative trial of the immunogenicity and safety of two. Immunization schedules (2, 3,4 months and 2,4,6 months of age) using diphtheria, tetanus, acellular pertussis, polio (DTacP-IPV) vaccine mixed with Haemophilus influenzae Woe b (AcT-HIB) vaccine.
